SynAct Pharma - Management presents topline results from Phase 2b ADVANCE study with Q&A

Investor Studios

651 views • 2026-06-10

Added: 1 week ago

On June 15 at 10.00 CET, SynAct Pharma will present the topline results from the Phase 2b ADVANCE study with resomelagon in rheumatoid arthritis. Following t...